Nejsum Lene N, Christensen Tomas M, Robben Joris H, Milligan Graeme, Deen Peter M T, Bichet Daniel G, Levin Klaus
Department of Biology, Stanford University, Stanford, CA, USA.
NDT Plus. 2011 Jun;4(3):158-163. doi: 10.1093/ndtplus/sfr010. Epub 2011 Mar 2.
Mutations in the arginine vasopressin receptor 2 (AVPR2) gene can cause X-linked nephrogenic diabetes insipidus (NDI) characterized by the production of large amounts of urine and an inability to concentrate urine in response to the antidiuretic hormone vasopressin. We have identified a novel mutation in the AVPR2 gene (L170P) located in the fourth transmembrane domain in a Danish NDI male. Analysis of the mutant receptor in Madin-Darby Canine Kidney cell culture revealed that AVPR2-L170P was retained in the endoplasmic reticulum, and the expression was dramatically downregulated compared to wild-type AVPR2. Inhibition of the lysosome resulted in increased intracellular accumulation of AVPR2-L170P, indicating that AVPR2-L170P is downregulated via the lysosome. Inhibition of the proteasome resulted in plasma membrane localization of AVPR2-L170P, although the overall levels of AVPR2-L170P were unchanged.
精氨酸加压素受体2(AVPR2)基因突变可导致X连锁肾性尿崩症(NDI),其特征是产生大量尿液,且对抗利尿激素加压素无反应,无法浓缩尿液。我们在一名丹麦NDI男性中鉴定出位于第四跨膜结构域的AVPR2基因中的一个新突变(L170P)。在Madin-Darby犬肾细胞培养物中对突变受体的分析显示,AVPR2-L170P保留在内质网中,与野生型AVPR2相比,其表达显著下调。溶酶体的抑制导致AVPR2-L170P在细胞内的积累增加,表明AVPR2-L170P通过溶酶体被下调。蛋白酶体的抑制导致AVPR2-L170P定位于质膜,尽管AVPR2-L170P的总体水平未改变。